Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain
NCT02899884 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3765
Last updated 2019-11-22
Summary
The purpose of this study is to determine the prevalence of breakthrough cancer pain and characterize breakthrough cancer pain in an unselected, representative cohort of cancer outpatients with or without pain who attend consultations.
Conditions
- Breakthrough Cancer Pain
Interventions
- OTHER
-
No Intervention
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director Clinical Science · Takeda
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-14
- Primary Completion
- 2018-04-04
- Completion
- 2018-07-16
Countries
- Spain
Study Locations
More Related Trials
-
Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base
NCT05861245 ·Status: RECRUITING ·Phase: NA
-
Predicting Radiotherapy Response and Toxicities in Soft Tissue Sarcoma of the Extremities - Cohort B
NCT05978024 ·Status: RECRUITING
-
Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma
NCT04339218 ·Status: RECRUITING ·Phase: PHASE3
-
Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis
NCT01603849 ·Status: COMPLETED ·Phase: NA
-
Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.
NCT04823377 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Data Base Project for Acquisition of Cancer Patient Data in Practices and Ambulant Therapy
NCT02303353 ·Status: UNKNOWN
-
Radiation Therapy in Treating Patients With Metastatic Spinal Cord Compression
NCT00727584 ·Status: COMPLETED ·Phase: NA
-
CPR Prediction After Neoadjuvant Using Excisional Biopsy By Radiofrequency In Breast Cancer From II-III UICC Stages.
NCT01984866 ·Status: TERMINATED
-
Stereotactic Volumetric Radiotherapy in Prostate Cancer
NCT02423889 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Study of Cryoablation for Palliation of Painful Bone Metastases
NCT02511678 ·Status: COMPLETED ·Phase: NA
-
Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer
NCT02379039 ·Status: COMPLETED
-
Investigating the Tumour Immune Response of Radiotherapy
NCT05076500 ·Status: RECRUITING
-
NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer
NCT04484909 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer
NCT03408665 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant Tumors
NCT02838602 ·Status: RECRUITING ·Phase: NA
-
E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
NCT03818503 ·Status: RECRUITING
-
Thermal Testing in Bone Pain (TiBoP)
NCT02887833 ·Status: COMPLETED
-
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
NCT04892849 ·Status: RECRUITING
-
Comparative Evaluation of Two Different Radiosurgery
NCT02355613 ·Status: COMPLETED ·Phase: NA
-
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
NCT02275286 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer
NCT01647555 ·Status: COMPLETED
-
Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases
NCT05406063 ·Status: RECRUITING ·Phase: NA
-
NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers
NCT02721056 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma
NCT02787642 ·Status: COMPLETED ·Phase: PHASE1
-
Analysis of Percutaneous Ablations for Cancer Treatment
NCT01563679 ·Status: COMPLETED